Diffuse Large B-Cell Lymphoma
Open accessThe DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
DLBCL, an aggressive cancer, accounts for about 30% of all lymphomas. Empirical combination chemotherapy cures about 65% of patients initially, with another 20 to 25% cured with salvage therapy. Efforts are ongoing to tailor therapy to particular genetic lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707447 · Cited by 6,030
Cheson, B. D., Fisher, R. I., Barrington, S. F., Cavalli, F., Schwartz, L. H., Zucca, E., & Lister, T. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.8800 · Cited by 5,715
Coiffier, B., Lepage, E., Brière, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011795 · Cited by 5,574
Self-citationA Predictive Model for Aggressive Non-Hodgkin's Lymphoma
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291402 · Cited by 4,949
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Schuster, S. J., Bishop, M. R., Tam, C. S., Waller, E. K., Borchmann, P., McGuirk, J. P., Jäger, U., Jaglowski, S., Andreadis, C., Westin, J. R., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1804980 · Cited by 4,112
Self-citationRosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Abramson, J. S., Palomba, M. L., Gordon, L. I., Lunning, M. A., Wang, M., Arnason, J., Mehta, A., Purev, E., Maloney, D. G., Andreadis, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31366-0 · Cited by 2,430
Locke, F. L., Ghobadi, A., Jacobson, C. A., Miklos, D. B., Lekakis, L. J., Oluwole, O. O., Lin, Y., Braunschweig, I., Hill, B. T., Timmerman, J. M., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30864-7 · Cited by 2,286
Chapuy, B., Stewart, C., Dunford, A. J., Kim, J., Kamburov, A., Redd, R. A., Lawrence, M. S., Roemer, M. G. M., Li, A. J., Ziepert, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0016-8 · Cited by 1,941
Stromal Gene Signatures in Large-B-Cell Lymphomas
Lenz, G., Wright, G., Dave, S. S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802885 · Cited by 1,808
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
Crump, M., Neelapu, S. S., Farooq, U., Van Den Neste, E., Kuruvilla, J., Westin, J., Link, B. K., Hay, A., Cerhan, J. R., Zhu, L., et al. (2017) · Blood · doi:10.1182/blood-2017-03-769620 · Cited by 1,703
Barrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Müeller, S. P., Schwartz, L. H., Zucca, E., Fisher, R. I., Trotman, J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5229 · Cited by 1,665
Gisselbrecht, C., Glass, B., Mounier, N., Singh Gill, D., Linch, D. C., Trneny, M., Bosly, A., Ketterer, N., Shpilberg, O., Hagberg, H., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.1618 · Cited by 1,625
Sehn, L. H., Berry, B., Chhanabhai, M., Fitzgerald, C., Gill, K., Hoskins, P., Klasa, R., Savage, K. J., Shenkier, T., Sutherland, J., et al. (2007) · Blood · doi:10.1182/blood-2006-08-038257 · Cited by 1,473
Self-citationHabermann, T. M., Weller, E. A., Morrison, V. A., Gascoyne, R. D., Cassileth, P. A., Cohn, J. B., Dakhil, S. R., Woda, B., Fisher, R. I., Peterson, B. A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1003 · Cited by 1,355
Wright, G. W., Huang, D. W., Phelan, J. D., Coulibaly, Z. A., Roulland, S., Young, R. M., Wang, J. Q., Schmitz, R., Morin, R. D., Tang, J., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.015 · Cited by 1,169
Pfreundschuh, M., Schubert, J., Ziepert, M., Schmits, R., Mohren, M., Lengfelder, E., Reiser, M., Nickenig, C., Clemens, M., Peter, N., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70002-0 · Cited by 1,130
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
Advani, R., Flinn, I., Popplewell, L., Forero, A., Bartlett, N. L., Ghosh, N., Kline, J., Roschewski, M., LaCasce, A., Collins, G. P., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1807315 · Cited by 1,126
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wilson, W. H., Young, R. M., Schmitz, R., Yang, Y., Pittaluga, S., Wright, G., Lih, C.-J., Williams, P. M., Shaffer, A. L., Gerecitano, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3884 · Cited by 1,113
Miller, T. P., Dahlberg, S., Cassady, J. R., Adelstein, D. J., Spier, C. M., Grogan, T. M., LeBlanc, M., Carlin, S., Chase, E., & Fisher, R. I. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390104 · Cited by 1,004
Johnson, N. A., Slack, G. W., Savage, K. J., Connors, J. M., Ben-Neriah, S., Rogic, S., Scott, D. W., Tan, K. L., Steidl, C., Sehn, L. H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0985 · Cited by 975
Self-citationZhou, Z., Sehn, L. H., Rademaker, A. W., Gordon, L. I., LaCasce, A. S., Crosby-Thompson, A., Vanderplas, A., Zelenetz, A. D., Abel, G. A., Rodriguez, M. A., et al. (2014) · Blood · doi:10.1182/blood-2013-09-524108 · Cited by 930
Self-citationPolatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sehn, L. H., Herrera, A. F., Flowers, C. R., Kamdar, M. K., McMillan, A., Hertzberg, M., Assouline, S., Kim, T. M., Kim, W. S., Ozcan, M., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.00172 · Cited by 774
Self-citationDavids, M. S., Roberts, A. W., Seymour, J. F., Pagel, J. M., Kahl, B. S., Wierda, W. G., Puvvada, S., Kipps, T. J., Anderson, M. A., Salem, A. H., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.4320 · Cited by 748
Younes, A., Sehn, L. H., Johnson, P., Zinzani, P. L., Hong, X., Zhu, J., Patti, C., Belada, D., Samoilova, O., Suh, C., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02403 · Cited by 608
Self-citationPeyrade, F., Jardin, F., Thieblemont, C., Thyss, A., Emile, J.-F., Castaigne, S., Coiffier, B., Haioun, C., Bologna, S., Fitoussi, O., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70069-9 · Cited by 553
Salles, G., Duell, J., González Barca, E., Tournilhac, O., Jurczak, W., Liberati, A. M., Nagy, Z., Obr, A., Gaidano, G., André, M., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30225-4 · Cited by 533
Self-citationCheson, B. D., Ansell, S., Schwartz, L., Gordon, L. I., Advani, R., Jacene, H. A., Hoos, A., Barrington, S. F., & Armand, P. (2016) · Blood · doi:10.1182/blood-2016-05-718528 · Cited by 521
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma
Kurtz, D. M., Scherer, F., Jin, M. C., Soo, J., Craig, A. F. M., Esfahani, M. S., Chabon, J. J., Stehr, H., Liu, C. L., Tibshirani, R., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.5246 · Cited by 497
Post-Transplantation Lymphoproliferative Disorders in Adults
Dierickx, D., & Habermann, T. M. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1702693 · Cited by 481
Petrich, A. M., Gandhi, M., Jovanovic, B., Castillo, J. J., Rajguru, S., Yang, D. T., Shah, K. A., Whyman, J. D., Lansigan, F., Hernandez-Ilizaliturri, F. J., et al. (2014) · Blood · doi:10.1182/blood-2014-05-578963 · Cited by 467
Crump, M., Kuruvilla, J., Couban, S., MacDonald, D. A., Kukreti, V., Kouroukis, C. T., Rubinger, M., Buckstein, R., Imrie, K. R., Federico, M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.9593 · Cited by 462
Schmitz, N., Zeynalova, S., Nickelsen, M., Kansara, R., Villa, D., Sehn, L. H., Glass, B., Scott, D. W., Gascoyne, R. D., Connors, J. M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.6520 · Cited by 453
Self-citationHutchings, M., Morschhauser, F., Iacoboni, G., Carlo-Stella, C., Offner, F. C., Sureda, A., Salles, G., Martínez-Lopez, J., Crump, M., Thomas, D. N., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.03175 · Cited by 437
Self-citationBartlett, N. L., Wilson, W. H., Jung, S.-H., Hsi, E. D., Maurer, M. J., Pederson, L. D., Polley, M.-Y. C., Pitcher, B. N., Cheson, B. D., Kahl, B. S., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01994 · Cited by 434
Vitolo, U., Trněný, M., Belada, D., Burke, J. M., Carella, A. M., Chua, N., Abrisqueta, P., Demeter, J., Flinn, I., Hong, X., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.3402 · Cited by 417
Self-citationEnnishi, D., Jiang, A., Boyle, M., Collinge, B., Grande, B. M., Ben-Neriah, S., Rushton, C., Tang, J., Thomas, N., Slack, G. W., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01583 · Cited by 414
Self-citationMaurer, M. J., Ghesquières, H., Jais, J.-P., Witzig, T. E., Haioun, C., Thompson, C. A., Delarue, R., Micallef, I. N., Peyrade, F., Macon, W. R., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.5866 · Cited by 411
Self-citationScott, D. W., Mottok, A., Ennishi, D., Wright, G. W., Farinha, P., Ben-Neriah, S., Kridel, R., Barry, G. S., Hother, C., Abrisqueta, P., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.2383 · Cited by 405
Self-citationViardot, A., Goebeler, M.-E., Hess, G., Neumann, S., Pfreundschuh, M., Adrian, N., Zettl, F., Libicher, M., Sayehli, C., Stieglmaier, J., et al. (2016) · Blood · doi:10.1182/blood-2015-06-651380 · Cited by 378
Ruppert, A. S., Dixon, J. G., Salles, G., Wall, A., Cunningham, D., Poeschel, V., Haioun, C., Tilly, H., Ghesquieres, H., Ziepert, M., et al. (2020) · Blood · doi:10.1182/blood.2019002729 · Cited by 365
Self-citationRécher, C., Coiffier, B., Haioun, C., Molina, T. J., Fermé, C., Casasnovas, O., Thiéblemont, C., Bosly, A., Laurent, G., Morschhauser, F., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61040-4 · Cited by 355
Self-citationAnsell, S. M., Minnema, M. C., Johnson, P., Timmerman, J. M., Armand, P., Shipp, M. A., Rodig, S. J., Ligon, A. H., Roemer, M. G. M., Reddy, N., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.00766 · Cited by 353
Kalakonda, N., Maerevoet, M., Cavallo, F., Follows, G., Goy, A., Vermaat, J. S. P., Casasnovas, O., Hamad, N., Zijlstra, J. M., Bakhshi, S., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30120-4 · Cited by 339
Palanca-Wessels, M. C. A., Czuczman, M., Salles, G., Assouline, S., Sehn, L. H., Flinn, I., Patel, M. R., Sangha, R., Hagenbeek, A., Advani, R., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70128-2 · Cited by 336
Self-citationJacobsen, E. D., Sharman, J. P., Oki, Y., Advani, R. H., Winter, J. N., Bello, C. M., Spitzer, G., Palanca-Wessels, M. C., Kennedy, D. A., Levine, P., et al. (2015) · Blood · doi:10.1182/blood-2014-09-598763 · Cited by 300
Nowakowski, G. S., Chiappella, A., Gascoyne, R. D., Scott, D. W., Zhang, Q., Jurczak, W., Özcan, M., Hong, X., Zhu, J., Jin, J., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01366 · Cited by 275
Davies, A., Cummin, T. E., Barrans, S., Maishman, T., Mamot, C., Novak, U., Caddy, J., Stanton, L., Kazmi-Stokes, S., McMillan, A., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30935-5 · Cited by 273
Linet, M. S., Vajdic, C. M., Morton, L. M., de Roos, A. J., Skibola, C. F., Boffetta, P., Cerhan, J. R., Flowers, C. R., de Sanjose, S., Monnereau, A., et al. (2014) · JNCI Monographs · doi:10.1093/jncimonographs/lgu006 · Cited by 242
Lin, J. K., Muffly, L. S., Spinner, M. A., Barnes, J. I., Owens, D. K., & Goldhaber-Fiebert, J. D. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02079 · Cited by 240
Sehn, L. H., Scott, D. W., Chhanabhai, M., Berry, B., Ruskova, A., Berkahn, L., Connors, J. M., & Gascoyne, R. D. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.3419 · Cited by 232
Self-citationThieblemont, C., Tilly, H., Gomes da Silva, M., Casasnovas, R.-O., Fruchart, C., Morschhauser, F., Haioun, C., Lazarovici, J., Grosicka, A., Perrot, A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.6984 · Cited by 194
Self-citationLeonard, J. P., Kolibaba, K. S., Reeves, J. A., Tulpule, A., Flinn, I. W., Kolevska, T., Robles, R., Flowers, C. R., Collins, R., DiBella, N. J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.2784 · Cited by 186
High total metabolic tumor volume at baseline predicts survival independent of response to therapy
Vercellino, L., Cottereau, A.-S., Casasnovas, O., Tilly, H., Feugier, P., Chartier, L., Fruchart, C., Roulin, L., Oberic, L., Pica, G. M., et al. (2020) · Blood · doi:10.1182/blood.2019003526 · Cited by 186
Self-citationSchuster, S. J., Bartlett, N. L., Assouline, S., Yoon, S.-S., Bosch, F., Sehn, L. H., Cheah, C. Y., Shadman, M., Gregory, G. P., Ku, M., et al. (2019) · Blood · doi:10.1182/blood-2019-123742 · Cited by 182
Self-citationHamadani, M., Radford, J., Carlo-Stella, C., Caimi, P. F., Reid, E., O’Connor, O. A., Feingold, J. M., Ardeshna, K. M., Townsend, W., Solh, M., et al. (2021) · Blood · doi:10.1182/blood.2020007512 · Cited by 178
Mounier, N., El Gnaoui, T., Tilly, H., Canioni, D., Sebban, C., Casasnovas, R.-O., Delarue, R., Sonet, A., Beaussart, P., Petrella, T., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.090597 · Cited by 174
Self-citationCerhan, J. R., Berndt, S. I., Vijai, J., Ghesquières, H., McKay, J., Wang, S. S., Wang, Z., Yeager, M., Conde, L., de Bakker, P. I. W., et al. (2014) · Nature Genetics · doi:10.1038/ng.3105 · Cited by 170
Self-citationCzuczman, M. S., Trněný, M., Davies, A., Rule, S., Linton, K. M., Wagner-Johnston, N., Gascoyne, R. D., Slack, G. W., Brousset, P., Eberhard, D. A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2818 · Cited by 162
Self-citationCerhan, J. R., Kricker, A., Paltiel, O., Flowers, C. R., Wang, S., Monnereau, A., Blair, A. E., Maso, L. D., Kane, E. V., Nieters, A., et al. (2014) · JNCI Monographs · doi:10.1093/jncimonographs/lgu010 · Cited by 162
Maurer, M. J., Ghesquières, H., Link, B. K., Jaïs, J., Habermann, T. M., Thompson, C. A., Haïoun, C., Allmer, C., Johnston, P. B., Delarue, R., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.5198 · Cited by 159
Self-citationPersky, D. O., Li, H., Stephens, D. M., Park, S. I., Bartlett, N. L., Swinnen, L. J., Barr, P. M., Winegarden, J. D., Constine, L. S., FitzGerald, T. J., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00999 · Cited by 155
Klánová, M., Sehn, L. H., Bence‐Bruckler, I., Cavallo, F., Jin, J., Martelli, M., Stewart, D. A., Vitolo, U., Zaja, F. F., Zhang, Q., et al. (2019) · Blood · doi:10.1182/blood-2018-07-862862 · Cited by 144
Self-citationJurczak, W. J., Zinzani, P. L., Gaïdano, G., Goy, A. H., Provencio, M., Nagy, Z., Robak, T., Maddocks, K. J., Buske, C., Ambarkhane, S., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy056 · Cited by 141
Cheah, C. Y., Herbert, K. E., O’Rourke, K., Kennedy, G., George, A., Fedele, P. L., Gilbertson, M., Tan, S., Ritchie, D., Opat, S., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.405 · Cited by 139
Crump, M., Leppä, S., Fayad, L., Lee, J. J., Rocco, A. D., Ogura, M., Hagberg, H., Schnell, F. M., Rifkin, R. M., Mackensen, A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.7171 · Cited by 134
Nowakowski, G. S., Hong, F., Scott, D. W., Macon, W. R., King, R. L., Habermann, T. M., Wagner‐Johnston, N. D., Casulo, C., Wade, J. L., Nagargoje, G. G., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01375 · Cited by 123
Freeman, C. L. L., Savage, K. J. J., Villa, D. R., Scott, D. W., Srour, L., Gerrie, A. S., Brown, M. J., Slack, G. W., Farinha, P., Skinnider, B., et al. (2020) · Blood · doi:10.1182/blood.2020005846 · Cited by 108
Self-citationBannerji, R., Allan, J. N., Arnason, J. E., Brown, J. R., Advani, R. H., Ansell, S. M., O'Brien, S. M., Duell, J., Martin, P., Joyce, R., et al. (2020) · Blood · doi:10.1182/blood-2020-136659 · Cited by 107
Fields, P. A., Townsend, W. M., Webb, A., Counsell, N., Pocock, C., Smith, P., Jack, A., El-Mehidi, N., Johnson, P., Radford, J. A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.7586 · Cited by 102
Eyre, T. A., Djebbari, F., Kirkwood, A. A., & Collins, G. P. (2019) · Haematologica · doi:10.3324/haematol.2019.229948 · Cited by 83
Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Wang, Y., Farooq, U., Link, B. K., Larson, M. C., King, R. L., Maurer, M. J., Allmer, C., Hefazi, M., Thompson, C. A., Micallef, I. N., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.00014 · Cited by 74
Witzig, T. E., Tobinai, K., Rigacci, L., Ikeda, T., Vanazzi, A., Hino, M., Shi, Y., Mayer, J., Costa, L. J., Bermúdez, C., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx764 · Cited by 69
Hutchings, M., Mous, R., Clausen, M. R., Johnson, P., Linton, K., Chamuleau, M. E. D., Lewis, D. J., Sureda, A. M., Cunningham, D., Oliveri, R. S., et al. (2020) · Blood · doi:10.1182/blood-2020-133820 · Cited by 66
Moccia, A. A., Schaff, K., Freeman, C. L. L., Hoskins, P. J., Klasa, R. J., Savage, K. J. J., Shenkier, T. N., Gascoyne, R. D., Connors, J. M., & Sehn, L. H. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020002982 · Cited by 45
Self-citationRutherford, S. C., Herold, M. J., Hiddemann, W., Kostakoglu, L., Marcus, R. E., Martelli, M., Sehn, L. H., Trněný, M., Trotman, J., Vitolo, U., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001261 · Cited by 23
Self-citation
Cited by
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
Locke, F. L., Miklos, D. B., Jacobson, C. A., Perales, M.-A., Kersten, M.-J., Oluwole, O. O., Ghobadi, A., Rapoport, A. P., McGuirk, J., Pagel, J. M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2116133 · Cited by 1,607
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Tilly, H., Morschhauser, F., Sehn, L. H., Friedberg, J. W., Trněný, M., Sharman, J. P., Herbaux, C., Burke, J. M., Matasar, M., Rai, S., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2115304 · Cited by 926
Self-citationGlofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Dickinson, M. J., Carlo-Stella, C., Morschhauser, F., Bachy, E., Corradini, P., Iacoboni, G., Khan, C., Wróbel, T., Offner, F., Trněný, M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206913 · Cited by 761
Thieblemont, C., Phillips, T., Ghesquieres, H., Cheah, C. Y., Clausen, M. R., Cunningham, D., Do, Y. R., Feldman, T., Gasiorowski, R., Jurczak, W., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.01725 · Cited by 584
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
Bishop, M. R., Dickinson, M., Purtill, D., Barba, P., Santoro, A., Hamad, N., Kato, K., Sureda, A., Greil, R., Thieblemont, C., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2116596 · Cited by 538
Metadata
- Authors
- Sehn, L. H., & Salles, G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-03-04
- Volume
- 384
- Issue
- 9
- Pages
- 842-858
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3134205746
- Cited by
- 1,175
- References
- 76
- FWCI
- 91.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.